Table 1.
Metabolic and anthropometric characteristics of the studied populations
| Characteristics | Control (n = 19) | T2DM < 10 (n = 20) | T2DM > 10 (n = 20) |
|---|---|---|---|
| Age (years) | 44.0 ±10.6 | 52.7 ±7.31a | 52.6 ±9.11a |
| BMI (kg/m2) | 28.5 ±6.1 | 33.1 ±6.0a | 27.8 ±4.2b |
| FPG (mg/dl) | 89.5 ±10.9 | 141.3 ±73.6a | 154.2 ±56.9a |
| HbA1c (%) | 5.9 ±0.6 | 6.6 ±1.2a | 7.0 ±1.2a |
| Urea (mg/dl) | 36.3 ±7.9 | 38.1 ±9.9 | 37.8 ±9.1 |
| Creatinine (mg/dl) | 0.9 ±0.2 | 0.9 ±0.2 | 1.1 ±1.3 |
| Triglycerides (mg/dl) | 123.7 ±37.6 | 183.2 ±106.6a | 197.2 ±142.9a |
| Total cholesterol (mg/dl) | 171.0 ±24.3 | 180.6 ±20.6 | 181.±29.5 |
| HDL cholesterol (mg/dl) | 60.0 ±6.2 | 59.6 ±7.9 | 59.4 ±8.3 |
| LDL cholesterol (mg/dl) | 85.7 ±23.2 | 88.5 ±20.3 | 82.1 ±25.7 |
| VLDL cholesterol (mg/dl) | 24.7 ±7.5 | 36.6 ±21.3a | 37.3 ±28.0a |
| Treatment | |||
| Metformin | NA | 13/20 | 20/20 |
| Glibendamide | NA | 4/20 | 12/20 |
Data are shown as means ±SD; BMI – body mass index, FPG – fasting plasma glucose, HbAlc – hemoglobin A1c, LDL-c – low-density lipoprotein cholesterol, HDL-c – high-density lipoprotein cholesterol, NA – not applicable; p < 0.05, a compared with controls, b compared with T2DM < 10